Despite this opposite timeline, our data suggest that the overexpression of MYC, alteration of the NFkB pathway and large chromosomal gains are essential for the development of a large fraction of PC tumors in both the Vk*MYC mouse and in humans, as also recently confirmed in another GEMM of MM30. The gene discussed is NFKB1; the disease is pachyonychia congenita.